FluidForm

FluidForm is the world leader in functional human tissue for research, repair, and replacement. Our patented FRESH 3D printing technology is the most advanced biofabrication platform in the world, as published in Science. The company’s robust pipeline includes development and preclinical programs addressing significant unmet need in human health. These programs include bioprosthetic implantable medical devices, and a new generation of structurally and compositionally complex tissue models to test drug efficacy and cardiotoxicity, with an ultimate focus on tissue and organ replacement. FluidForm is in the Boston area.

FluidForm is transforming medicine by creating human tissue for drug discovery, surgical repair, and organ transplant. By integrating 3D printing, computational and synthetic biology, AI and Machine Learning, and advanced materials science, we are developing human tissue applications that deliver on the promise of Medicine 4.0.

By recreating the complex structure and function of human tissue, FluidForm will revolutionize how drugs are discovered and developed, surgery is performed, and diseased organs are replaced.